Hamlet BioPharma featured at MSQ’s CEO Webinar series released during the JP Morgan Health Care Conference 2024
Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along with an extensive project and patent portfolio, is delighted to announce the webinar, hosted by MSQ ventures in the MSQ’s CEO Webinar series, released during the JP Morgan Health Care Conference 2024, this week. Register in advance for this webinar:https://us02web.zoom.us/webinar/register/WN_VbVV8FrXTYmtyOF16AmWWw MSQ Ventures and BioAroundWorld are collaborating to host a bi-weekly MSQ CEO Webinar Series